Single-cell T-cell landscape in atherosclerosis: implications for targeted therapy and beyond
- 1Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
- 2Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. [email protected]
Abstract
BACKGROUND: Atherosclerosis (AS) progression is profoundly influenced by dynamic T-cell heterogeneity and functional plasticity. MAIN BODY: This review consolidates the latest insights derived from single-cell transcriptomic technologies, which are transforming our understanding of the role of the immune system in plaque pathogenesis. Recent evidence revealed previously unrecognized T-cell subsets within murine and human atherosclerotic lesions, distinguished by unique transcriptional profiles and adaptability driven by their microenvironment. Spatial mapping techniques have revealed compartment-specific distributions of T cells across vascular layers, whereas temporal analyses have highlighted age-related changes in the balance between effector and regulatory functions. Notably, single-cell resolution delineated transitional states between cytotoxic and regulatory lineages, suggesting that local inflammatory signals play a crucial role in determining T-cell fate. Despite these advancements, challenges remain in fully understanding T-cell lineage commitment, plasticity, and interactions with vascular niches. The integration of emerging multiomics approaches and spatial transcriptomics holds promise for addressing these challenges, providing a roadmap for novel therapeutic strategies. This includes not only the development of targeted immunotherapies but also the identification of key molecular targets for drug intervention and precision diagnostics, ultimately broadening the horizon for clinical applications in atherosclerosis. CONCLUSIONS: This review synthesizes single-cell RNA sequencing-driven discoveries in AS immunology, highlighting the heterogeneity and plasticity of plaque T-cell subsets. These insights lay the groundwork for developing targeted immunotherapies and identifying novel molecular targets and diagnostic biomarkers, ultimately advancing precision medicine for AS patients.
Related
- Familial Pancreatic Cancer Associated with a Shared BRIP1 Variant: Implications for Homologous Recombination Deficiency and Targeted Therapy
- Dendritic cells in atherosclerosis: integrating ontogeny, functional states, spatial organization, and therapeutic implications
- Deciphering Vascular Smooth Muscle Cell Phenotype Switching via Integrated Single-Cell Transcriptomics and Machine Learning: CX3CR1 and COL1A1 as Novel Diagnostic Biomarkers for Atherosclerosis
- Single-cell landscape of lymphoid and myeloid heterogeneity across type-stratified craniofacial lesions in polyostotic fibrous dysplasia
- Single-cell transcriptomics reveals the heterogeneous landscape of innate lymphoid cells in zebrafish
BibTeX
@article{luo2026singlecell,
title = {{Single-cell T-cell landscape in atherosclerosis: implications for targeted therapy and beyond}},
author = {Renfei Luo and Shixing Liu and Xin Ouyang and Enge Zhou and Long Jiang},
journal = {Journal of Translational Medicine},
year = {2026},
month = jun,
doi = {10.1186/s12967-026-08334-4},
url = {https://doi.org/10.1186/s12967-026-08334-4},
note = {CC BY},
}
RIS
TY - JOUR
TI - Single-cell T-cell landscape in atherosclerosis: implications for targeted therapy and beyond
AU - Renfei Luo
AU - Shixing Liu
AU - Xin Ouyang
AU - Enge Zhou
AU - Long Jiang
PY - 2026
DA - 2026/06/10
JO - Journal of Translational Medicine
DO - 10.1186/s12967-026-08334-4
UR - https://doi.org/10.1186/s12967-026-08334-4
AB - BACKGROUND: Atherosclerosis (AS) progression is profoundly influenced by dynamic T-cell heterogeneity and functional plasticity. MAIN BODY: This review consolidates the latest insights derived from single-cell transcriptomic technologies, which are transforming our understanding of the role of the immune system in plaque pathogenesis. Recent evidence revealed previously unrecognized T-cell subsets within murine and human atherosclerotic lesions, distinguished by unique transcriptional profiles and adaptability driven by their microenvironment. Spatial mapping techniques have revealed compartment-specific distributions of T cells across vascular layers, whereas temporal analyses have highlighted age-related changes in the balance between effector and regulatory functions. Notably, single-cell resolution delineated transitional states between cytotoxic and regulatory lineages, suggesting that local inflammatory signals play a crucial role in determining T-cell fate. Despite these advancements, challenges remain in fully understanding T-cell lineage commitment, plasticity, and interactions with vascular niches. The integration of emerging multiomics approaches and spatial transcriptomics holds promise for addressing these challenges, providing a roadmap for novel therapeutic strategies. This includes not only the development of targeted immunotherapies but also the identification of key molecular targets for drug intervention and precision diagnostics, ultimately broadening the horizon for clinical applications in atherosclerosis. CONCLUSIONS: This review synthesizes single-cell RNA sequencing-driven discoveries in AS immunology, highlighting the heterogeneity and plasticity of plaque T-cell subsets. These insights lay the groundwork for developing targeted immunotherapies and identifying novel molecular targets and diagnostic biomarkers, ultimately advancing precision medicine for AS patients.
SN - 1479-5876
ER -